Technology
StepChange shares rise on strong quarterly earnings update
Perth-based StepChange (ASX:STH) achieved quarterly revenue of $15.2 million, supported by an EBITDA of $1.5 million.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Technology
Texas Instruments revenue hits $4.83B as industrial and data center demand surges
Texas Instruments (NASDAQ:TXN) reported its financial results for the first quarter of 2026, signaling a significant recovery in the semiconductor sector.
First Community profit rises on Signature Bank of Georgia acquisition
First Community Corporation (NASDAQ:FCCO), the holding company for First Community Bank, delivered a robust start to 2026, reporting net income of $5.498 million, or $0.59 per diluted share.
BankUnited reports $62M net income as asset quality improves sharply
BankUnited (NYSE:BKU) reported first-quarter 2026 net income of $62 million, or $0.83 per diluted share.
Stifel Financial revenue hits $1.48B following record investment banking growth
Stifel Financial (NYSE:SF) delivered a powerful start to 2026, reporting record first-quarter net revenues of $1.48 billion.
Technology
Otis service growth offsets China new equipment slump as revenue reaches $3.6B
Otis Worldwide (NYSE:OTIS) delivered a resilient first-quarter performance for 2026, reporting net sales of $3.6 billion.
Cboe Global Markets to sell Australia and Canada exchange units to TMX Group for $300M
Cboe Global Markets (CBOE) has entered into a definitive agreement to sell its Australian and Canadian exchange operations to TMX Group for an aggregate purchase price of $300 million.
Cryptocurrency
Aave whales buy as retail exits after exploit
Aave is showing signs of whale accumulation even as retail users exit following the fallout from the KelpDAO exploit, which left the protocol with an estimated $196 million in bad debt.
Moderna initiates Phase 3 trial for H5 pandemic flu vaccine to bolster global readiness
Moderna (NASDAQ:MRNA) announced a significant milestone in global health security on April 22, 2026, with the dosing of the first participants in the United States and the United Kingdom for its Phase 3 clinical trial of mRNA-1018.
Cryptocurrency
Kelp hack shakes banks’ blockchain adoption plans
A $293 million exploit of Kelp DAO has raised concerns that traditional financial institutions may slow blockchain adoption as they reassess security risks.